Gradually , interest is developing within the UK regarding Tesamorelin as a potential solution for lipodystrophy . While largely new , understanding of the advantages it offers – particularly in managing the symptoms of HIV-related lipodystrophy – is spreading . Doctors are investigating its suitability, and patient inquiries is growing, sugge